R Havlík
- Co-authors
- Nagy HabibRagai R. MitryCatherine SarrafJoanna P. NichollsS L JensenMartin KöcherHosny SalamaVladimı́r Král
- Topics
- Pancreatic and Hepatic Oncology Research (17 papers)Virus-based gene therapy research (9 papers)Cancer Research and Treatments (6 papers)
- Cited by
- OncologyGeneticsBiotechnology
- Partner nations
- CzechiaUnited KingdomUnited States
In The Last Decade
R Havlík
45 papers receiving 611 citations
Peers
Comparison fields: 5 of 67
- Oncology 300
- Genetics 222
- Molecular Biology 221
- Surgery 183
- Pulmonary and Respiratory Medicine 136
Countries citing papers authored by R Havlík
This map shows the geographic impact of R Havlík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Havlík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Havlík more than expected).
Fields of papers citing papers by R Havlík
This network shows the impact of papers produced by R Havlík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Havlík. The network helps show where R Havlík may publish in the future.
Co-authorship network of co-authors of R Havlík
This figure shows the co-authorship network connecting the top 25 collaborators of R Havlík. A scholar is included among the top collaborators of R Havlík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Havlík. R Havlík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | [Postpancreatectomy haemorrhage (PPH), prevalence, diagnosis and management]. | 7 |
| 4 | 47 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 12 | |
| 8 | [Surgical therapy of pancreatic cancer - 5 years survival]. | 2 |
| 9 | 6 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 64 | |
| 14 | Combination of optison with ultrasound and electroporation increases albumin and thrompoietin transgene expression whilst elongation factor promoter prolongs its duration | 3 |
| 15 | 4 | |
| 16 | 24 | |
| 17 | 5 | |
| 18 | 93 | |
| 19 | 8 | |
| 20 | 40 |
About R Havlík
R Havlík is a scholar working on Oncology, Biotechnology and Hepatology, having authored 46 papers that have together received 621 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (17 papers), Virus-based gene therapy research (9 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Oncology (300 citations), Genetics (222 citations) and Biotechnology (60 citations). R Havlík has collaborated with scholars based in Czechia, United Kingdom and United States. Frequent co-authors include Nagy Habib, Ragai R. Mitry, Catherine Sarraf, Joanna P. Nicholls, S L Jensen, Martin Köcher, Hosny Salama, Vladimı́r Král, Martin Loveček and Jiří Ehrmann. Their work appears in journals such as Hepatology, Biochemical Pharmacology and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.